Proprietary neural network, cloud-based AI-powered technology designed to support clearer ECG signal interpretation across care settings. TORONTO, ON / ACCESS Newswire / May 15, 2025 /AI/ML ...

In April 2025, Invivyd secured a $30 million non-dilutive term loan facility with Silicon Valley Bank, a division of First Citizens Bank, supporting balance sheet optionality and providing potential ...

Alembic Pharmaceuticals advanced 1.10% to Rs 918.15 after the company received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Rivaroxaban ...

AbbVie has claimed its first regulatory approval, from the FDA, for its C-met-targeting antibody-drug conjugate (ADC) Emrelis ...

As recently as March, the FDA approved the IL-23 inhibitor guselkumab (Tremfya, Johnson & Johnson/Janssen) for patients with Crohn’s disease, offering both IV and subcutaneous induction options.

A multi-billion-dollar development is coming to eastern Montgomery County. It's called the Viva White Oak Project.